Patrice François

Dr. Patrice François

University Hospital of Geneva, Geneva, Genève, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2011 in Diabetes
Verified
Journal Article
Open access
AEAmandine Everard
Amandine Everard
VLVladimir Lazarevic
Vladimir Lazarevic
MDMuriel Derrien
Muriel Derrien
MGMyriam Girard
Myriam Girard
GMGiulio G Muccioli
Giulio G Muccioli
Patrice CaniPatrice Cani
Patrice Cani
OBJECTIVE: To investigate deep and comprehensive analysis of gut microbial communities and biological parameters after prebiotic administration in obese and diabetic mice. RESEARCH DESIGN AND METHODS: Genetic (ob/ob) or diet-induced obese and diabetic mice were chronically fed with prebiotic-enriched diet or with a control diet. Extensive gut microbiota analyses, including quantitative PCR, pyrosequencing of the 16S rRNA, and phylogenetic microarrays, were performed in ob/ob mice. The impact of gut microbiota modulation on leptin sensitivity was investigated in diet-induced leptin-resistant mice. Metabolic parameters, gene expression, glucose homeostasis, and enteroendocrine-related L-cell function were documented in both models. RESULTS: In ob/ob mice, prebiotic feeding decreased Firmicutes and increased Bacteroidetes phyla, but also changed 102 distinct taxa, 16 of which displayed a >10-fold change in abundance. In addition, prebiotics improved glucose tolerance, increased L-cell number and associated parameters (intestinal proglucagon mRNA expression and plasma glucagon-like peptide-1 levels), and reduced fat-mass development, oxidative stress, and low-grade inflammation. In high fat–fed mice, prebiotic treatment improved leptin sensitivity as well as metabolic parameters. CONCLUSIONS: We conclude that specific gut microbiota modulation improves glucose homeostasis, leptin sensitivity, and target enteroendocrine cell activity in obese and diabetic mice. By profiling the gut microbiota, we identified a catalog of putative bacterial targets that may affect host metabolism in obesity and diabetes.

3 April 2014 in The ISME Journal
Verified
Journal Article
Open access
PDF file
AEAmandine Everard
Amandine Everard
VLVladimir Lazarevic
Vladimir Lazarevic
NGNadia Gaïa
Nadia Gaïa
MJMaria Johansson
Maria Johansson
MHMarcus Henricsson
Marcus Henricsson
Patrice CaniPatrice Cani
Patrice Cani
The gut microbiota is involved in metabolic and immune disorders associated with obesity and type 2 diabetes. We previously demonstrated that prebiotic treatment may significantly improve host health by modulating bacterial species related to the improvement of gut endocrine, barrier and immune functions. An analysis of the gut metagenome is needed to determine which bacterial functions and taxa are responsible for beneficial microbiota–host interactions upon nutritional intervention. We subjected mice to prebiotic (Pre) treatment under physiological (control diet: CT) and pathological conditions (high-fat diet: HFD) for 8 weeks and investigated the production of intestinal antimicrobial peptides and the gut microbiome. HFD feeding significantly decreased the expression of regenerating islet-derived 3-gamma (Reg3g) and phospholipase A2 group-II (PLA2g2) in the jejunum. Prebiotic treatment increased Reg3g expression (by ∼50-fold) and improved intestinal homeostasis as suggested by the increase in the expression of intectin, a key protein involved in intestinal epithelial cell turnover. Deep metagenomic sequencing analysis revealed that HFD and prebiotic treatment significantly affected the gut microbiome at different taxonomic levels. Functional analyses based on the occurrence of clusters of orthologous groups (COGs) of proteins also revealed distinct profiles for the HFD, Pre, HFD-Pre and CT groups. Finally, the gut microbiota modulations induced by prebiotics counteracted HFD-induced inflammation and related metabolic disorders. Thus, we identified novel putative taxa and metabolic functions that may contribute to the development of or protection against the metabolic alterations observed during HFD feeding and HFD-Pre feeding.

10 March 2008 in Genome Research
Verified
Journal Article
Closed access
PDF file
DHDavid Hernandez
David Hernandez
PFPatrice François
Patrice François
LFLaurent Farinelli
Laurent Farinelli
MØMagne Østerås
Magne Østerås
JSJacques Schrenzel
Jacques Schrenzel
Novel high-throughput DNA sequencing technologies allow researchers to characterize a bacterial genome during a single experiment and at a moderate cost. However, the increase in sequencing throughput that is allowed by using such platforms is obtained at the expense of individual sequence read length, which must be assembled into longer contigs to be exploitable. This study focuses on the Illumina sequencing platform that produces millions of very short sequences that are 35 bases in length. We propose a de novo assembler software that is dedicated to process such data. Based on a classical overlap graph representation and on the detection of potentially spurious reads, our software generates a set of accurate contigs of several kilobases that cover most of the bacterial genome. The assembly results were validated by comparing data sets that were obtained experimentally for Staphylococcus aureus strain MW2 and Helicobacter acinonychis strain Sheeba with that of their published genomes acquired by conventional sequencing of 1.5- to 3.0-kb fragments. We also provide indications that the broad coverage achieved by high-throughput sequencing might allow for the detection of clonal polymorphisms in the set of DNA molecules being sequenced.

1 September 1999 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
Bhanu SinhaBhanu Sinha
Bhanu Sinha
PFPatrice François
Patrice François
ONOliver Nusse
Oliver Nusse
MFMichelangelo Foti
Michelangelo Foti
OHOrla M. Hartford
Orla M. Hartford
KKKarl-Heinz Krause
Karl-Heinz Krause
The ability of Staphylococcus aureus to invade mammalian cells may explain its capacity to colonize mucosa and to persist in tissues after bacteraemia. To date, the underlying molecular mechanisms of...

1 January 1994 in Molecular Microbiology
Verified
Journal Article
Closed access
PDF file
DMD. McDevitt
D. McDevitt
PFPatrice François
Patrice François
PVP. Vaudaux
P. Vaudaux
TFT. J. Foster
T. J. Foster

1 June 2011 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
PFPatrice François
Patrice François
MTManuela Tangomo
Manuela Tangomo
JHJonathan Hibbs
Jonathan Hibbs
EBEve-Julie Bonetti
Eve-Julie Bonetti
CBCatharina C. Boehme
Catharina C. Boehme
JSJacques Schrenzel
Jacques Schrenzel
We evaluated the robustness of loop-mediated isothermal amplification (LAMP) of DNA for bacterial diagnostic applications. Salmonella enterica serova